BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• Aibio Biotechnology made a successful presence at Medic East Africa 2023

  Anbio, a global leading provider of innovative diagnostic solutions, made a successful exhibition at Medic East Africa 2023 from September 13th to 15th.

  September 19, 2023

   · 

  2 min read
• Biotech Beach

  10x Wins Injunction From Unified Patent Court Banning Sales of NanoString’s CosMx Products in Europe

  10x Genomics, Inc., a leader in single cell and spatial biology, announced that the European Unified Patent Court issued a preliminary injunction against NanoString Technologies, Inc. for infringing European Patent 4 108 782 B1.

  September 19, 2023

   · 

  9 min read
• Cayman Chemical Receives CEP for Latanoprost API from EDQM

  Cayman Chemical, a world leader in the manufacture of prostaglandins for both research use and as active pharmaceutical ingredients

  September 19, 2023

   · 

  1 min read
• ChoiceSpine® Announces Standalone Indication for Blackhawk® Ti 3D Printed Cervical Spacer System

  ChoiceSpine LLC, a privately held spinal device company held by Altus Capital Partners in Knoxville, TN, is pleased to announce today that it has received clearance from the U.S. Food and Drug Administration (FDA) to market the Blackhawk® Ti 3D Printed Cervical Spacer System with standalone clearance.

  September 19, 2023

   · 

  3 min read
• Nostics Appoints Medtech Leader Jeroen Nieuwenhuis as CEO

  19th of September 2023 - Nostics, a medical diagnostics startup, is thrilled to announce the appointment of veteran medtech entrepreneur

  September 19, 2023

   · 

  2 min read
• Drug Development

  Kiora Pharmaceuticals Completes Last Patient, Last Visit in Phase 1B Trial of KIO-301 in Patients with Retinitis Pigmentosa

  Kiora Pharmaceuticals (NASDAQ: KPRX) today announced the completion of the final patient’s last endpoint evaluation from the ABACUS study of KIO-301.

  September 19, 2023

   · 

  3 min read
• Navigating CMC Challenges in NBE and Therapeutic Antibody Development

  In April 2021, the FDA approved the 100th monoclonal antibody as a therapeutic entity, a milestone that took 35 years to reach. As of the fall of 2022, the FDA has approved 162 antibody

  September 19, 2023

   · 

  6 min read
• Moss to Launch Revolutionary 90-Second Urine Test and Smartphone App

  Moss Genomics Inc. (CSE: MOSS) (“Moss” or the “Company”), an innovator in the health technology industry

  September 19, 2023

   · 

  4 min read
• BioMidwest

  Medline adds SNF Metrics to its post-acute care technology solutions portfolio

  Medline announced an addition to its post-acute care technology solutions portfolio for nursing homes.

  September 19, 2023

   · 

  3 min read
• Pharm Country

  Eagle Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023

  Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that Scott Tarriff, Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will participate in a panel presentation at the Cantor Global Healthcare Conference 2023.

  September 19, 2023

   · 

  1 min read